Med Surg Exam 3 Notes PDF

Summary

These notes cover medical-surgical topics, including fluid resuscitation calculations, burn assessment, cerebral perfusion pressure (CPP), and altered level of consciousness (LOC) management. They detail treatment for ischemic strokes and increased intracranial pressure (ICP), along with monitoring and management strategies.

Full Transcript

‭EXAM 3 NOTES‬ ‭CALCULATIONS:‬ ‭ URN FLUID RESUSCITATION‬ B -‭ ‬ ⇒ ‭Electrical + Thermal burns 2 ml LR * weight (kg) * % TBSA … Chemical ⇒ double (4 ml LR)‬ ‭-‬ ‭TOTAL needs to be administered within 24 hours o...

‭EXAM 3 NOTES‬ ‭CALCULATIONS:‬ ‭ URN FLUID RESUSCITATION‬ B -‭ ‬ ⇒ ‭Electrical + Thermal burns 2 ml LR * weight (kg) * % TBSA … Chemical ⇒ double (4 ml LR)‬ ‭-‬ ‭TOTAL needs to be administered within 24 hours of INJURY‬ ‭-‬ ‭½ within first 8 hours‬ ‭-‬ ‭½ over next 16 hours‬ ‭-‬ ‭Ex: total = 2000 ml‬ ‭-‬ ‭1000 ml in first 8 hours : 1000/8 = 125 ml/hr‬ ‭-‬ ‭1000 ml in next 16 hours : 1000/16 = 62.5 ml/hr‬ ‭-‬ ‭BUT based on pt’s response…‬ ‭-‬ ‭Appropriate resuscitation:‬ ‭-‬ ‭Thermal + Chemical‬ ‭-‬ ‭Urine output 0.5-1 ml/kg/hr‬ ‭-‬ ‭Electrical‬ ‭-‬ ‭Urine output 75-100 ml/hr‬ ‭-‬ ‭hr/bp NOT useful in assessing intravascular volume of burn pts‬ ‭TBSA - RULE OF 9s‬‭… (Lund & Browder for peds)‬ ‭TOTAL = 100%‬ ‭-‬ ‭1 arm = 9%‬ ‭-‬ ‭anterior / posterior = 4.5%‬ ‭-‬ ‭1 leg = 18%‬ ‭-‬ ‭anterior / posterior = 9%‬ ‭-‬ ‭ANTERIOR chest (9) + abdomen (9) = 18%‬ ‭-‬ ‭POSTERIOR chest (9) + abdomen (9) = 18%‬ ‭-‬ ‭Genital area = 1%‬ ‭-‬ ‭Face = 9%‬ ‭-‬ ‭anterior / posterior = 4.5%‬ ‭ PP (central perfusion pressure)‬ C ‭CPP = MAP - ICP‬ ‭(way to remember : med surg before ICU)‬ t‭ PA dosage‬‭(ISCHEMIC STROKES within 2 HOURS of s/s‬‭ONSET… NOT arrival! … if onset unknown→‬ ‭contraindicated)‬ ‭Dosage … 0.9 mg/kg (MAX 90 mg)‬ ‭10% bolus over 1 minute … then 90% over 1 hour‬ ‭*ensure 2 IV sites prior to administration via infusion pump + frequent vitals/neuro checks‬ ‭*side effects: NO anticoags/platelet inhibitors + avoid tube/catheter placement for 24 hours‬ ‭NEURO‬ ‭CH 61 - NEURO DYSFUNCTION MANAGEMENT‬ ⇒ ‭ALTERED LOC‬‭ not oriented, can’t follow commands,‬‭needs persistent stimuli for alertness‬ ‭-‬ ‭** most important indicator of patient’s condition‬ ‭-‬ ‭Gauged on continuum from normal LOC → coma‬ ‭-‬ ‭Coma = unresponsive + unarousable‬ ‭-‬ ‭No purposeful response to internal/external stimuli‬ ‭-‬ ‭Intact internal structures of brain required for normal‬ ‭function**‬ ‭-‬ ‭Types…‬ ⇒ ‭-‬ ‭Akinetic mutism‬‭ state of unresponsiveness to environment‬ ‭with lack of ability to move/speak but eyes may follow or be‬ ‭diverted by sound‬ ⇒ ‭-‬ ‭Persistent vegetative state‬‭ pt resumes sleep/wake‬‭cycle after‬ ‭weeks in vegetative state with partial arousal but no true‬ ‭awareness‬ ⇒ ‭-‬ ‭Locked in syndrome‬‭ pt conscious/cognitively intact‬‭+ has‬ ‭senses but has no function except blinking‬ ‭-‬ ‭Pathophysiology…‬ ‭-‬ ‭Disruption in nervous system cells, NTs, or anatomy‬ ‭-‬ ‭Multiple phenomena‬ ‭-‬ ‭Neuro → head injury, stroke‬ ‭-‬ ‭Toxicologic → OD, alcohol intoxication‬ ‭-‬ ‭Metabolic → DKA, hepatic, kidney‬ ‭-‬ ‭Depends on cause + placement on LOC continuum‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭As state of LOC declines, changes occur in…‬ ‭-‬ ‭restlessness/anxiety, pupils slow to response to light / fixed if comatose,‬ ‭eye opening, verbal + motor response‬ ‭-‬ ‭As ICP increases, pt becomes more stuporous‬‭(reacting‬‭to only‬ ‭loud/painful stimuli)‬ ‭-‬ ‭Implies serious brain impairment + immediate intervention‬ ‭required‬ ‭-‬ ‭Abnormal posturing…‬ ‭-‬ ‭Decorticate‬‭= severe brain damage‬ ‭-‬ ‭plantar flexion, extension/‬‭internal rotation LE‬‭,‬‭flexion‬‭UE (elbow‬ ‭+ wrist)‬‭, adduction whole arm‬ ‭-‬ ‭Decerebrate‬‭= more severe damage of‬‭nuchal spinal‬‭tract indicating‬ ‭lesion lower in brainstem‬ ‭-‬ ‭ lantar flexion, extension/‬‭external rotation LE‬‭,‬‭extension elbow‬‭,‬ p ‭pronation forearm‬‭,‬‭wrist flexion‬ ‭-‬ ‭Increased ICP‬ ‭-‬ ‭Monro-Kelli hypothesis…‬ ‭-‬ ‭Increase in 1, causes decrease in one or both of others or‬ ‭increased ICP results‬ ‭-‬ ‭Tissue, blood, CSF‬ ‭-‬ ‭Pathophysiology…‬ ‭-‬ ‭Mostly d/t head injury‬ ‭-‬ ‭can be secondary to brain tumor, subarachnoid‬ ‭hemorrhage, toxic/viral encephalopathy‬ ‭-‬ ‭Decreases cerebral perfusion → further swelling‬ ‭-‬ ‭… herniation … ischemia + cell death‬ ‭-‬ ‭CO‬‭2‬ ‭concentration in blood plays role in cerebral‬‭blood‬ ‭flow → vasomotor centers stimulated to increased‬ ‭bp??? → slow bounding pulse + resp irregularities‬ ‭-‬ ‭Cerebral edema‬ ‭-‬ ‭Abnormal fluid accumulation in intra/extracellular‬ ‭space/both d/t increase in brain tissue volume‬ ‭-‬ ‭Autoregulation to compensate…‬ ‭-‬ ‭Brain’s ability to change vessel diameter to‬ ‭maintain constant cerebral blood flow‬ ‭-‬ ‭**ONLY if systolic 100-150 + ICP < 40‬ ‭-‬ ‭Cerebral perfusion pressure = MAP - ICP‬ ‭-‬ ‭If autoregulation ineffective + cerebral perfusion‬ ‭declines significantly…‬ ‭-‬ ‭Cushing’s response/reflex/triad‬ ⇒ ‭-‬ ‭ bradycardia, hypertension,‬ ‭bradypnea‬ ‭-‬ ‭Assess …‬ ‭-‬ ‭Mental status‬ ‭-‬ → ‭ GCS (scale of 3-15,‬‭≤ 8 = requires intubation + mech vent‬‭;‬ ‭mild=13-15)‬ ‭-‬ ‭Eye opening, verbal response, motor response‬ ‭-‬ ‭ex… E2, V4, M6 = 12‬ ‭-‬ ‭**monitor trends to see where dysfunction lies‬ ‭-‬ ‭Cranial nerve function‬ ‭-‬ ‭Cerebellar function → balance + coordination‬ ‭-‬ ‭Reflexes‬ ‭-‬ ‭Motor + sensory function‬ ‭-‬ ‭d/x…‬ ‭-‬ ‭CT, MRI, MRS, EEG‬ -‭ ‬ ‭ ET or SPECT‬ P ‭-‬ ‭Transcranial Dopper study or cerebral angiography for cerebral blood flow‬ ‭-‬ ‭Lumbar puncture…‬ ‭-‬ ‭Usually avoided with LOC changes‬‭d/t increased ICP‬‭causing herniation‬ ‭of brain‬ ‭-‬ ‭labs…‬ ‭-‬ ‭Blood glucose‬ ‭-‬ ‭Electrolytes‬ ‭-‬ ‭Ammonia + LFTs‬ ‭-‬ ‭BUN / creatinine‬ ‭-‬ ‭Calcium level‬ ‭-‬ ‭Coags + PT‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭ btain/maintain patent airway‬ o ‭-‬ ‭Maintain adequate oxygenation + ventilation‬ ‭-‬ ‭BP, HR to assess circulatory status‬ ‭-‬ ‭IV fluids/meds‬ ‭-‬ ‭Neurologic care‬ ‭-‬ ‭Nutritional support‬ ‭-‬ ‭Prevent complications‬ ‭-‬ ‭Lower ICP…‬ ‭-‬ ‭Monitor‬‭CSF volume‬‭through osmotic diuretics, restrict‬‭fluids, drain CSF‬ ‭carefully, reduce fever / metabolic demands‬ ‭-‬ ‭Detect early (‬‭ventriculostomy – intraventricular catheter‬‭into lateral‬ ‭ventricle to measure ICP through transducer‬‭) for early‬‭treatment‬ ‭-‬ ‭Complications… meningitis, ventricular collapse, catheter‬ ‭occlusion (brain tissue, blood)‬ ‭-‬ ‭Aseptic technique when draining bag‬ ‭-‬ ‭Coughing discouraged because increases ICP‬ ‭-‬ ‭Decrease cerebral edema‬ ‭-‬ ‭Osmotic diuretics → mannitol or 3% NS‬ ‭-‬ ‭Assess for HF/pulmonary edema because are hypertonic solns‬ ‭-‬ ‭If‬‭brain tumor is cause → corticosteroids‬ -‭ ‬ ‭Maintaining hypothermia has not confirmed if effective but is still performed‬ ‭-‬ ‭Maintain cerebral perfusion‬ ‭-‬ ‭Dobutamine, norepinephrine to maintain CPP > 70‬ ‭-‬ ‭Control fever d/t increasing metabolic demands‬ ‭-‬ ‭Antipyretics, hypothermia blankets,‬‭correct any shivering‬ ‭-‬ ‭Maintain oxygenation + reduce metabolic demands‬ ‭-‬ ‭High dose barbiturates if unresponsive to conventional sedatives‬‭→‬ ‭requires continuous cardiac monitoring, ET intubation/mech ventilation,‬ ‭monitor MAP/ICP‬ ‭-‬ ‭Nursing Process‬ ‭-‬ ‭assess‬ ‭-‬ ‭verbal response, alertness, motor response‬ ‭-‬ ‭resp status, eyes (including edema), reflexes, body functions‬ ‭-‬ ‭d/x + plan/goals/evaluation‬ ‭-‬ ‭based on assessment data…‬ ‭-‬ ‭Ineffective airway clearance‬ ‭-‬ ‭Maintain airway → manage secretions, HOB 30, lateral‬ ‭or semi prone position, auscultate at least q8h, mech‬ ‭ventilation interventions‬ ‭-‬ ‭Risk for injury‬ ‭-‬ ‭Pad side rails (2 raised - 4 considered restraint if intent is‬ ‭to limit mobility, if a&ox4 and asks - then not restraint‬ ‭and can raise), identify potential sources of injury,‬ ‭ensure pt’s dignity during altered LOC‬ ‭-‬ ‭Fluid volume imbalance‬ ‭-‬ ‭IV fluids given slowly to reduce risk of increased ICP‬ ‭-‬ ‭Feeding tube if needed‬ ‭-‬ ‭Risk for imbalanced nutrition r/t inability to ingest food‬ ‭-‬ ‭Impaired elimination‬ ‭-‬ ‭Prevent urinary retention‬ ‭-‬ ‭Bladder palpation + scans regularly‬ ‭-‬ ‭Intermittent straight cath / indwelling to‬ ‭measure output (but increases infection risk)‬ ‭-‬ ‭Condom cath / primafit‬ ‭-‬ ‭As soon as continent → bladder training‬ ‭program initiated‬ ‭-‬ ‭Promoting bowel function‬ ‭-‬ ‭Assess regularly for distention, bowel sounds,‬ ‭girth with tape measure‬ ‭-‬ ‭Monitor #/consistency of BMs + rectal exam for‬ ‭s/s fecal impaction‬ ‭-‬ ‭Stool softeners (can be given with tube feeds)‬ ‭-‬ ‭Ineffective health maintenance‬ ‭-‬ ‭Restoring health maintenance‬ ‭-‬ ‭All senses (including kinesthetic) to stimulate pt‬ ‭emerging from coma‬ ‭-‬ ‭**once risk of increased ICP not an‬ ‭issue‬ ‭-‬ ‭Provide daily rhythm‬ ‭-‬ ‭Interrupted family processes‬ ‭-‬ ‭Meet family’s needs‬ -‭ ‬ ‭ einforce/clarify information + validate‬ R ‭-‬ ‭Encourage family involvement in talking +‬ ‭touching pt‬ ‭-‬ ‭**unless stimulation disturbs/agitates‬ ‭pt‬ ‭-‬ ‭Allow for frequent rest periods‬ ⇒ ‭-‬ ‭Brain dead‬‭ irreversible brain dysfunction (can‬ ‭be pronounced‬‭before‬‭heart stops beating)‬ ‭-‬ ‭(risk for) impaired skin integrity‬ ‭-‬ ‭Mouth care to prevent infection‬ ‭-‬ ‭inspect for dryness/inflammation/crusting‬ ‭-‬ ‭cleanse/rinse carefully to remove‬ ‭secretions/crusts + keep membranes moist‬ ‭-‬ ‭Thin layer of petroleum‬ ‭-‬ ‭Move ET tube to opposite side of mouth daily to‬ ‭prevent ulceration‬‭of mouth/lips‬ ‭-‬ ‭Maintain skin + joint integrity‬ ‭-‬ ‭Regular turning schedule + correct positioning +‬ ‭passive ROM‬ ‭-‬ ‭Foam boots, trochanter rolls to prevent‬ ‭contractures‬ ‭-‬ ‭Maintain body temp → fever increases‬ ‭metabolic needs + insensible fluid loss‬ ‭-‬ ‭Minimal bedding used + lower room‬ ‭temp if pt has fever‬ ‭-‬ ‭Administered‬ ‭acetaminophen/ibuprofen‬ ‭-‬ ‭Cool sponge baths‬ ‭-‬ ‭Hypothermia blanket‬ ‭-‬ ‭Monitor temp frequently‬ ‭-‬ ‭Preserve corneal integrity to prevent ulceration‬ ‭-‬ ‭Clean with cotton balls moistened with sterile‬ ‭NS to remove debris/discharge‬ ‭-‬ ‭Prevent‬‭complications‬ ‭-‬ ‭Include ‬⇒ ‭-‬ ‭brainstem herniation‬‭d/t increased ICP in cranial‬ ‭bulb blocking blood flow to brain‬ ‭-‬ ‭neurogenic diabetes insipidus‬‭d/t decreased‬ ‭ADH secretion‬ ‭-‬ ‭Increased‬‭urine output + urine‬ ‭osmolality …FVD‬ ‭-‬ >‭ 200 ml/hour for 2 consecutive‬ ‭hours‬‭may indicate diabetes‬ ‭insipidus onset‬ ‭-‬ ‭SIADH‬‭d/t increased ADH‬ ‭-‬ ‭Decreased‬‭urine output +‬‭decreased‬ ‭serum Na conc …FVE‬ -‭ ‬ ‭Close vital sign monitoring‬ ‭-‬ ‭CBC/ABGs monitoring‬ ‭-‬ ‭Chest physiotherapy, suctioning, mouth care‬ ‭-‬ ‭Assess skin integrity frequently + turning + moisture‬ ‭protection‬ -‭ ‬ ‭Monitor s/s VTE + prevent‬ ‭-‬ ⇒ ‭Prevent contractures passive ROM per shift‬ ‭SEIZURE DISORDERS‬ ⇒ ‭-‬ ‭ sudden, uncontrolled episodes of abnormal motor/sensory activity d/t electrical disturbance‬ ‭in brain‬ ⇒ ‭-‬ ‭Epilepsy 2 unprovoked seizures > 24 hours apart‬ ‭-‬ ‭Types…‬ ‭-‬ ‭Focal‬ ⇒ ‭-‬ ‭Generalized both hemispheres‬ ‭-‬ ‭Unknown‬ ‭-‬ ‭Provoked (acute reversible condition - structural/metabolic/infectious etiology) vs‬ ‭Unprovoked‬ ‭-‬ ‭Causes include…‬ ‭-‬ ‭CV disease‬ ‭-‬ ‭Hypoxemia‬ ‭-‬ ‭Fever in childhood‬ ‭-‬ ‭TBI‬ ‭-‬ ‭HTN‬ ‭-‬ ‭CNS infection‬ ‭-‬ ‭Brain tumors‬ ‭-‬ ‭drug/alcohol withdrawal‬ ‭-‬ ‭Allergies‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Depends on location of discharging neurons‬ ‭-‬ ‭Generalized‬‭absence‬‭→ simple staring episode to prolonged‬‭convulsive movements with‬ ‭loss of LOC‬ ‭-‬ ‭Generalized‬‭tonic-clonic seizure‬‭→ intense rigidity‬‭of entire body + alternating mm.‬ ‭relaxation/contraction‬ ‭-‬ ‭bite tongue, incontinent‬ ‭-‬ ‭Usually‬‭subsides after 2 min and enters postictal‬‭state‬‭(sleepy + hard to arouse,‬ ‭headache/fatigue/depression after awaken)‬ ‭-‬ ‭assess…‬ ‭-‬ ‭type of seizure, frequency, severity, precipitating factors‬ ‭-‬ ‭h/x events + pregnancy/childbirth h/x + PMH‬ ‭-‬ ‭d/x…‬ ‭-‬ ‭CT/MRI‬‭for‬‭structural/focal abnormality‬ ‭-‬ ‭EEG‬‭→‬‭classify‬‭seizure‬ ‭-‬ ‭SPECT‬‭→‬‭identify zones‬‭of brain‬‭producing seizures‬ ‭-‬ ‭nursing management…‬ ‭-‬ ‭during seizure‬ ‭-‬ ‭Observe + record + document sequence of events!! (before, during, stimuli, aura‬ ‭noted, body parts involved, incontinence, pupil responses, duration)‬ ‭-‬ ‭Observe + record + document postictal stage‬ ‭-‬ ‭Administer meds‬ ‭-‬ ‭Injury prevention…‬ ‭-‬ ‭Hypoxia + aspiration → lateral position + suctioning + nothing in mouth‬ ‭-‬ ‭Side rails padded‬ ‭-‬ ‭Allow rest‬ ‭Status Epilepticus (SEIZURE)‬ ⇒ ‭-‬ ‭ ‬‭series of generalized seizures occurring without‬‭full recovery of LOC between attacks‬‭=‬ ‭medical emergency‬‭d/t‬‭potential irreversible damage‬‭**‬ ‭-‬ ‭causes…‬ ‭-‬ ‭Missing anticonvulsant med dose‬ ‭-‬ ‭Fever / infection‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Goal‬‭=‬‭stop seizures asap‬‭+ ensure‬‭cerebral oxygenation‬‭+ maintain‬‭seizure-free state‬ ‭-‬ ‭IV benzodiazepines‬ ‭-‬ ‭Prevent‬‭seizure →‬‭phenytoin, phenobarbital‬ ‭-‬ ‭EEG + ECG monitoring‬ ‭-‬ ‭IV dextrose if d/t hypoglycemia‬ ‭-‬ ‭nursing management…‬ ‭-‬ ‭Protect from injury‬ ‭-‬ ‭Prevent aspiration‬ ‭-‬ ‭Monitor IV line d/t potential dislodgement during seizure‬ ‭-‬ ‭pt education…‬ ‭-‬ ‭Long term anticonvulsant use causes increased fracture risk d/t bone disease‬ ‭(‬‭OP, osteomalacia, hyperparathyroidism‬‭)‬ ‭HEADACHE‬ ‭-‬ ‭= most common of all human physical complains (s/x rather than disease)‬ ‭-‬ ‭Cranial arteritis = common cause‬ ‭-‬ ‭s/s usually begin more general → fatigue, malaise, weight loss, fever‬ ⇒ ‭-‬ ‭Primary headache no organic cause identified‬ ‭-‬ ‭Includes‬ ⇒ ‭-‬ ‭Migraine‬‭ characterized by‬‭periodic / recurrent attacks‬‭of‬‭severe headache‬ ‭from‬‭hours - days‬‭in adults with‬‭photophobia and nausea‬ ⇒ ‭-‬ ‭Tension headache‬‭ ‬‭most common‬‭,‬‭chronic‬‭,‬‭less severe‬ ‭-‬ ‭Trigeminal Autonomic Cephalalgia‬ ⇒ ‭-‬ ‭Cluster headache‬‭ relatively‬‭uncommon‬‭+‬‭M > F‬ ⇒ ‭-‬ ‭Paroxysmal hemicrania ‬‭recurrent, unilateral‬‭headache‬‭attacks that‬ ‭are typically‬‭short in duration (2-30 min)‬‭but can‬‭occur frequently‬ ‭throughout the day‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭migraine w/ aura‬‭, 4 phases:‬ ‭-‬ ‭1)‬‭premonitory‬ ‭-‬ ‭experienced by‬‭> 80% adult migraine sufferers‬ ‭-‬ ‭s/s‬‭occur‬‭hours-days before headache phase‬ ‭-‬ ‭2)‬‭aura phase‬ ‭-‬ ‭characterized by‬‭focal neurologic s/s + visual disturbances‬‭– most‬ ‭common +‬‭hemianopic (half of visual field)‬ ‭-‬ ‭3)‬‭headache phase‬ ‭-‬ ‭severe + incapacitating‬‭. associated with‬‭photophobia,‬‭phonophobia,‬ ‭perception of innocuous stimuli → N/V‬ ‭-‬ ‭4)‬‭postdrome phase‬ ‭-‬ ‭pain gradually subsides‬ ‭-‬ ‭weak, fatigue, cognitive disability, mood changes‬‭hours-days‬ ‭-‬ ‭Tension-type‬ ‭-‬ ‭steady/constant pressure‬‭in‬‭forehead/temples/back‬‭of neck‬ ‭-‬ ‭“weight in top of head”‬ ‭-‬ ‭cluster headache‬ ‭-‬ ‭unilateral‬ ‭-‬ ‭8-10/day → lasts 15 min-3 hours‬‭with‬‭crescendo/decrescendo‬‭pattern‬ ‭-‬ ‭pain in‬‭eye/orbit radiating to facial/temporal‬‭regions‬ ‭-‬ ‭plus‬‭watery eyes + nasal congestion‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Abortive approach‬‭=‬‭relieve/limit‬‭headache at onset/while‬‭in progress‬ ‭-‬ ‭Preventive approach‬‭= experience more frequency attacks‬‭at regular or predictable‬ ‭intercans OR contraindicated for abortive therapy‬ ‭-‬ ‭ex…‬‭triptans‬‭used for‬‭vasoconstriction, reduce inflammation,‬‭reduce pain‬ ‭transmission‬ ‭-‬ ‭1st line for moderate-severe migraine pain‬ ‭-‬ ‭Contraindicated with‬‭HTN → preventive approach instead‬ ‭-‬ ‭other meds:‬ ‭-‬ ‭Ergotamine‬‭preparation → PO, SL, SQ, IM, PR, inhalation‬ ‭-‬ ‭Effective for‬‭aborting headache if taken early‬ -‭ ‬ ‭Preventive → anticonvulsants, beta blockers, antidepressants‬ ‭-‬ ‭For‬‭cluster headaches…‬ ‭-‬ ‭100% O‬‭2‬ ‭by face mask for 15 min‬ ‭-‬ ‭SQ sumatriptan‬ ‭-‬ ‭intranasal med‬ ‭-‬ ‭For‬‭cranial arteritis…‬ ‭-‬ ‭Corticosteroids‬‭to reduce inflammation and prevent‬‭occlusion →‬‭can cause‬ ‭vision loss‬ ‭-‬ ‭nursing management…‬ ‭-‬ ‭Goal = pain relief‬ ‭-‬ ‭1st priory = t/x acute event‬ ‭-‬ ‭2nd priority = prevent recurring episodes‬ ‭-‬ ‭Education…‬ ‭-‬ ‭Understand precipitate factors + make lifestyle factors (ex: smoking,‬ ‭chemical exposure)‬ ‭-‬ ‭Pain relief depends on type of headache…‬ ‭-‬ ‭Migraine = abortive meds in early phase‬‭d/t causing‬‭N/V and uncontrollable pain‬ ‭later in headache‬ ⇒ ‭-‬ ‭Comfort measures anti nausea med, dim light/noise, HOB 30‬ ‭-‬ ‭Tension headache‬ ‭-‬ ‭Local heat or massage‬ ⇒ ‭-‬ ‭Other strategies analgesics, antidepressants, muscle relaxants‬ ‭CH 62 - CEREBROVASCULAR DISORDER aka STROKE MANAGEMENT‬ ‭-‬ ‭CH 63 - NEURO TRAUMA MANAGEMENT‬ -‭ ‬ ‭ ead injury = any damage to head d/t trauma (doesn’t have to be to brain)‬ H ‭-‬ ⇒ ‭TBI injury d/t external force that interferes with daily life‬ ⇒ ‭-‬ ‭Primary injury‬‭ consequence of‬‭direct contact‬ ‭-‬ ‭Ex: laceration, contusion, external hematoma, skull fracture, subdural‬ ‭hematoma, concussion‬ ⇒ ‭-‬ ‭Secondary injury‬‭ evolves over time‬‭d/t inadequate‬‭O2/nutrient delivery‬‭to cells‬ ‭-‬ ‭Monro-Kellie Hypothesis…‬ ‭-‬ ‭Cranial vault = closed system with brain, blood, CSF‬ ‭-‬ ‭If any component increases in volume, one or both of others must decrease or ICP will‬ ‭increase … leads to anoxic brain cells … causing ischemia, infarction, herniation, brain‬ ‭death‬ ‭-‬ ‭SCALP INJURY‬ ‭-‬ ‭Minor injury‬ ‭-‬ S‭ calp bleeds profusely d/t poorly constricting blood vessels (causing it to‬‭look more‬ ‭serious than it may be‬‭)‬ ‭-‬ ‭Large avulsion can be fatal though‬ ‭-‬ ‭Infection risk / portal of entry‬ ⇒ ‭-‬ ‭Subgaleal hematomas‬‭ ‬‭blood collection under skin‬‭but above skull‬ ‭-‬ ‭… usually‬‭reabsorbs without any specific treatments‬ ‭-‬ ‭SKULL FRACTURES‬ ‭-‬ ‭Break in skull continuity d/t forceful trauma‬ ‭-‬ ‭Classified by…‬ ‭-‬ ‭Type‬ ‭-‬ ‭Linear‬ ⇒ ‭-‬ ‭Comminuted‬‭ splintered/‬‭multiple fracture lines‬ ⇒ ‭-‬ ‭Depressed‬‭ bones of skull‬‭forcefully displaced downward‬‭occupying‬ ‭space in cranial vault‬ ‭-‬ ‭Location‬ ‭-‬ ‭Frontal‬ ‭-‬ ‭Temporal‬ ‭-‬ ‭Basal‬‭… *** NG tube insertion contraindicated!!‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Cranial vault fractures may (not) produce swelling in region of fracture‬ ‭-‬ ‭Basal skull fracture‬‭→ hemorrhage in nose, pharynx,‬‭ears, or under conjunctiva‬ ‭-‬ ‭can include‬‭CSF leakage‬‭… bad!‬ ‭-‬ ‭meningeal infection can occur‬‭if pathogens gain access‬‭to cranial vault‬ ⇒ ‭-‬ ‭Battle sign‬‭ ecchymosis over mastoid bone‬ ‭-‬ ‭Gerontologic considerations…‬ ‭-‬ ‭Difference in etiology‬ ‭-‬ ‭Mostly d/t MVCs and falls‬ ‭-‬ ‭Higher mortality + longer hospital stay‬ ‭-‬ ‭Poor functional outcomes‬ ‭-‬ ‭Neuro assessment challenges → preexisting cognitive issues, visual/auditory‬ ‭deficits‬ ‭-‬ ‭Fall risk‬ ‭-‬ ‭Anticoag/antiplatelet agents increase bleeding risk‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Close monitoring‬ ⇒ ‭-‬ ‭Non-depressed skull fracture‬‭ ‬‭no surgical t/x‬ ⇒ ‭-‬ ‭Depressed skull fracture‬‭ ‬‭elevate skull + debride‬‭within 24 hours‬ ‭-‬ ‭BRAIN INJURY‬ ‭-‬ ‭Contusion / Closed Head Injury‬‭= bruised area d/t‬‭acceleration/deceleration force or‬ ‭blunt trauma … brain tissue damaged but NO opening through skull‬ ‭-‬ ‭Contusion peaks in 18-36 hours‬ ‭-‬ ‭Assess → increased ICP noted by stupor/confusion‬ -‭ ‬ ‭ enetrating / Open Head Injury‬‭= object penetrates skull, enters brain, damages tissue‬ P ‭-‬ ‭Intracranial Hemorrhage‬‭= collection of blood in brain‬ ‭-‬ ‭s/s occur‬‭when‬‭hematoma large enough to cause brain‬‭distortion‬‭+ increased‬ ‭ICP‬ ‭-‬ ‭Usually‬‭delayed assessment d/t needing blood to collect‬‭to cause s/s‬ ‭-‬ ‭types…‬ ‭-‬ ‭Epidural hematoma‬‭= between‬‭skull + dura mater‬ ‭-‬ ‭s/s →‬‭brief loss LOC‬‭with‬‭period of lucidness‬‭while‬ ‭compensation occurring (d/t rapid CSF absorption to decrease‬ ‭ICP)‬‭→ restless, agitated, confused → coma, herniation‬‭→‬ ‭declining LOC, dilated/fixed pupils, paralysis of one extremity‬ ‭-‬ ‭Emergency requiring immediate‬‭intervention…‬ ‭-‬ ‭Burr holes‬ ‭-‬ ‭Remove clot + control bleeding‬ ‭-‬ ‭Subdural hematoma‬‭= between‬‭dura + brain‬ ‭-‬ ‭d/t trauma, coagulopathies, aneurysm rupture‬ ‭-‬ ‭Types…‬ ‭-‬ ‭Acute‬ ‭-‬ ‭Early loss of LOC‬‭,‬‭pupillary changes‬‭,‬‭hemiparesis‬ ‭-‬ ‭Emergency needing‬‭immediate craniotomy +‬ ‭clot removal‬ ‭-‬ ‭Chronic‬ ‭-‬ ‭d/t minor injuries, coagulopathies‬ ‭-‬ ‭Less bleeding + venous in nature‬ ‭-‬ ‭Often mistaken for stroke‬ ‭-‬ ‭s/s‬‭→‬‭personality changes, focal seizures,‬ ‭headaches‬ ‭-‬ ‭t/x‬‭→‬‭Burr holes‬‭→‬‭craniotomy if needed‬ ‭-‬ ‭Concussion‬‭= temporary loss of neurological function‬‭without structural brain damage‬ ‭-‬ ‭Nursing management…‬ ‭-‬ ‭Observe + monitor trends/LOC‬ ‭-‬ ‭Pt education…‬ ‭-‬ ‭Monitor LOC‬ ‭-‬ ‭s/s to seek medical help → worsening headache, dizzy, seizures,‬ ‭abnormal/uneven pupil responses, headache vomiting, slurred‬ ‭speech, weakness/numbness, irritability‬ ‭-‬ ‭Diffuse Axonal Injury‬ ‭-‬ ‭d/t‬‭widespread shearing + rotational forces producing‬‭brain damage + increases‬ ‭ICP‬ ‭-‬ ‭s/s‬‭… severe head trauma with‬‭no lucid interval + no‬‭coma +‬ ‭decorticate/decerebrate posturing, global cerebral edema‬ ‭-‬ ‭d/x… CT, MRI, PET (in some trauma centers)‬ ‭-‬ ‭t/x‬‭…‬ ‭-‬ ‭Maintain‬‭C-spine alignment‬‭with cervical collar!!!‬ ‭-‬ ‭Assume spinal cord injury until r/o‬ ‭-‬ ‭GOAL =‬‭prevent secondary brain injury + maintain homeostasis‬ ‭-‬ ‭Supportive measures…‬ ‭-‬ ‭ventilation/intubation, seizure precautions, fluid/electrolyte‬ ‭management, nutritional support, pain/anxiety management,‬ ‭NGT to…‬ ‭-‬ ‭promote GI motility + prevent reverse peristalsis‬ → ‭ ‬ ‭regurgitation / aspiration risk / increases ICP‬ ‭-‬ ‭Sedation…‬ ‭-‬ ‭benzodiazepines used d/t not affecting cerebral blood‬ ‭flow or ICP‬ ‭-‬ ‭However, can produce toxic metabolites therefore…‬ ‭-‬ ‭Preferred sedation = PROPOFOL‬ ⇒ ‭-‬ ‭Brain dead potential organ donor‬ ‭-‬ ‭3 cardinal signs of death:‬ ‭-‬ ‭1)‬‭coma‬ ‭-‬ ‭2)‬‭absence of brainstem reflexes‬ ‭-‬ ‭3)‬‭apnea‬ ‭-‬ ‭Nursing Process…‬ ‭-‬ ‭Assess … head to toe including GCS‬ ‭-‬ ‭Nursing d/x … ineffective airway clearance, FVD, risk for injury‬ ‭-‬ ‭Too little/too much suctioning can increase ICP‬ ‭-‬ ‭Oral care to prevent VAP‬ ‭-‬ ‭Nutritional support d/t pt being in catabolic state‬ ‭-‬ ‭Maintain CPP between 50-70 mmHg‬ ‭-‬ ‭Prevent post traumatic seizures → can further increase ICP +‬ ‭cause secondary injury‬ ‭-‬ ‭SPINAL CORD INJURY‬ ‭-‬ ‭= injury to spinal cord, vertebral column, supporting soft tissue, or intervertebral discs‬ ‭-‬ ‭Commonly d/t MVC, falls, violence, sports‬ ‭-‬ ‭Risk factors‬ ‭-‬ ‭M gender #1‬ ‭-‬ ‭Alcohol / drug abuse‬ ‭-‬ ‭May lead to paraplegia or tetraplegia‬ ‭-‬ ‭…‬‭bladder control loss‬‭, urinary retention/distention‬ ‭-‬ ‭Lose sweating/vasal motor tone below level of injury‬ ‭-‬ ‭Marked reduction in BP d/t reduced peripheral vascular resistance‬ ‭-‬ ‭s/s..‬ ‭-‬ ‭Depends on type/level of injury‬ ‭-‬ c‭ omplete spinal cord lesion‬‭→‬‭loss of both sensory + motor‬ ‭communication‬ ‭-‬ ‭Incomplete spinal cord injury‬‭→‬‭some ability‬‭of spinal‬‭cord to relay‬ ‭messages is‬‭preserved‬ ‭-‬ ‭Injuries to‬‭T12 and above‬‭will‬‭impact respiratory‬‭function‬ ‭-‬ ‭C4 injury‬‭=‬‭permanent ventilation required‬‭d/t innervating‬ ‭diaphragm‬ ‭-‬ ‭T1-T6‬‭innervates intercostals‬ ‭-‬ ‭T6-T12‬‭innervates abdominal muscles‬ -‭ ‬ ‭Spinal cord ends‬‭at‬‭L1‬ ‭-‬ ‭t/x‬‭…‬ ‭-‬ R ‭ apid assessment, immobilization, stabilization‬‭to‬‭prevent secondary‬ ‭injury‬ ‭-‬ ‭Maintain cardiac/resp function‬ ‭-‬ ‭Meds…‬ ‭-‬ ‭High dose IV corticosteroids‬ ‭-‬ ‭O2‬‭to prevent hypoxemia + worsening neuro deficit‬ ‭-‬ ‭Skeletal fracture reduction/traction‬‭→‬‭ensure weights‬‭are‬ ‭unencumbered to maintain correct alignment‬ ‭-‬ ‭Surgical intervention if…‬ ‭-‬ ‭compression of spinal cord, results in‬‭fragmented/unstable‬ ‭vertebral bodies, wound/bony fragments in cord, neuro status‬ ‭deteriorating‬ ‭-‬ ‭Complications…‬ ‭-‬ ‭Spinal shock‬ ⇒ ‭-‬ ‭ sudden depression of reflex activity in spinal cord …‬‭muscles‬ ‭below injury paralyzed, flaccid, without sensation‬ ‭-‬ ‭Neurogenic shock‬ ⇒ ‭-‬ ‭ lose autonomy nervous system function‬‭below level‬‭of lesion‬ ‭… vital organs affected‬ ‭-‬ ‭hypotension, bradycardia, no sweating‬‭below level‬‭of‬ ‭injury due to blocked SNS‬ ‭-‬ ‭risk for VTE but same as risk for those with other‬ ‭traumatic injuries‬ ‭-‬ ‭Nursing Process…‬ ‭-‬ ‭Assess → airway, breathing, neuro exam‬ ‭-‬ ‭d/x → ineffective breathing pattern, impaired mobility, risk for injury‬ ‭-‬ ‭AUTONOMIC DYSREFLEXIA with SPINAL CORD INJURY‬ ‭-‬ ‭fatal‬‭emergency‬ ‭-‬ ‭=‬‭exaggerated response to stimuli harmless to those‬‭without SCI‬ ‭-‬ ‭Occurs in pts with‬‭lesion above T6, after shock subsided‬ ‭-‬ T‭ riggers → distention of visceral organs (especially bowel), distended bladder,‬ ‭skin stimulation (pressure) … all causing pain‬ ‭-‬ ‭Often d/t kinked foley catheter‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Pounding headache, paroxysmal hypertension‬‭, profuse‬‭diaphoresis‬ ‭ABOVE level of lesion‬‭, nausea,‬‭nasal congestion‬‭, bradycardia‬ ‭-‬ ‭nursing interventions…‬ ‭-‬ ‭Remove trigger‬ ‭-‬ ‭Reposition / examine skin, empty bladder, examine rectum for fecal‬ ‭mass, administer antihypertensives‬ ‭-‬ ‭Document + pt education‬ ‭CH 64 - NEURO INFECTIONS, AUTOIMMUNE DISORDERS, NEUROPATHY MANAGEMENT‬ ‭-‬ ‭INFECTIONS‬ ‭-‬ ‭MENINGITIS‬‭= inflammation of the meninges‬ ‭-‬ ‭3 causes: bacterial, viral, fungal‬ ‭-‬ ‭Septic (bacterial) or aseptic (viral, secondary to cancer/weak immune system like‬ ‭in HIV /AIDS)‬ ‭-‬ ‭Aseptic more frequent in summer + early fall‬ ‭-‬ ‭Septic peaks in winter + early spring‬ ‭-‬ ‭Dense community groups → college campuses + military bases‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Headache, fever,‬‭nuchal rigidity‬‭, photophobia, rash‬‭with some types,‬ ‭disorientation/memory loss → lethargy/coma with progression‬ ⇒ ‭-‬ ‭positive Kernig sign‬‭ pt supine with hip flexed and‬‭knee at 90 degrees‬ ‭-‬ ‭Positive = leg can’t be completely extended without pain‬ ‭-‬ ‭If bilateral pain —> meningeal irritation expected‬ ⇒ ‭-‬ ‭positive Brudzinski‬‭ ‬‭extension of neck causes hips‬‭+ knees to flex‬ ‭-‬ ‭More sensitive indicator‬‭for meningeal irritation‬‭than Kernig,‬ ‭BUT‬‭both NOT reliable‬ ‭-‬ ‭Prevention…‬ ‭-‬ ‭Meningococcal vaccine for 11-12 y/o with booster at 16 y/o‬ ‭-‬ ‭If‬‭close contact‬‭→‬‭rifampin / ciprofloxacin / ceftriaxone‬‭within 24 hours‬ ‭-‬ ‭t/x‬‭…‬ ‭-‬ ‭Early‬‭antibiotics that crosses BBB and passes subarachnoid‬‭space‬ ‭-‬ ‭Penicillin G‬‭and‬‭IV cephalosporin 3rd gen‬ ‭-‬ ‭Dexamethasone‬‭→‬‭before 1st dose of antibiotics then‬‭repeated‬ ‭q6h for 4 days‬ ‭-‬ ‭Blunts inflammatory response d/t bacterial lysis +‬ ‭improves outcomes‬ ‭-‬ ‭If hypovolemic / shock → volume expanders‬ ‭-‬ ‭Nursing management…‬ ‭-‬ ‭Droplet‬‭precautions‬‭for‬‭24 hours after antibiotic‬‭therapy‬ ‭-‬ ‭Pneumococcal meningitis‬‭NO isolation‬‭required‬ ‭-‬ ‭BRAIN ABSCESS‬ ‭-‬ ‭=‬‭collection of infectious material within brain tissue‬ ‭-‬ ‭Rare if immunocompetent →‬‭occurs mostly in immunocompromised‬‭pts‬ ‭-‬ ‭d/t intracranial surgery, penetrating head injury, tongue piercing‬ ‭-‬ ‭mostly d/t otitis media + rhinosinusitis‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭d/t abscess location, cerebral hemodynamic alterations‬ ‭-‬ ‭Headache usually worse in morning, fever, vomiting, focal neuro deficits‬ ‭(weakness, vision loss), s/s increased ICP with progression → declining‬ ‭LOC + seizures‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Control‬‭ICP‬ ‭-‬ ‭Drain abscess‬ ‭-‬ ‭Antibiotics‬ ‭-‬ ‭Corticosteroids‬‭to reduce cerebral edema‬‭if evidence‬‭of increased neuro‬ ‭deficits‬ ‭-‬ ‭Anticonvulsants‬‭to‬‭t/x or prevent seizures‬ ‭-‬ ‭HERPES SIMPLEX ENCEPHALITIS‬ ‭-‬ ‭=‬‭inflammatory process of brain tissue‬ ‭-‬ ‭Most common cause in US = herpes simplex‬ ‭-‬ ‭leads to →‬‭necrotizing hemorrhage‬‭with‬‭progressive‬‭deterioration of‬ ‭nerve cell bodies‬ ‭-‬ ‭s/s…‬ ⇒ ‭-‬ ‭Early‬‭ ‬‭fever, headache, confusion, hallucinations‬ ⇒ ‭-‬ ‭Late as necrosis develops‬‭ ‬‭behavioral changes, seizures,‬‭dysphasia,‬ ‭hemiparesis, altered LOC‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Antiviral agents (ex:‬‭acyclovir) for 3 weeks to prevent‬‭relapse‬ ‭-‬ ‭Slow IV administration over 1 hour to prevent crystallization in‬ ‭urine‬ ‭-‬ ‭Lower dose if renal insufficiency‬ ‭-‬ ‭Nursing interventions…‬ ‭-‬ ‭Frequent neuro assessments‬ ‭-‬ ‭Dim lights, limit noise/visitors, group care‬ ‭-‬ ‭Pain relief …‬‭caution with opioids d/t masking neuro‬‭s/s‬ ‭-‬ ‭Monitor for renal complications‬ ‭-‬ ‭Seizure precautions to prevent injury‬ ‭-‬ ‭ARTHROPOD-BORNE VIRUS ENCEPHALITIS aka ARBOVIRUSES‬ ‭-‬ ‭ /t‬‭blood-feeding arthropods (mosquitos, biting flies, ticks) → St. Louis + West‬ d ‭Nile‬ ‭-‬ ‭s/s on continuum…‬ ‭-‬ ‭Flu s/s → coma‬ ‭-‬ ‭SIADH with hyponatremia‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭No cure‬ ‭-‬ ‭s/s management →‬‭control seizures + ICP‬ ‭-‬ ‭meds…‬ ‭-‬ ‭Interferon for St. Louis encephalitis‬ ‭-‬ ‭Usually on outpatient basis‬ ‭-‬ ‭Nursing interventions…‬ ‭-‬ ‭Identity improvement/deterioration‬ ‭-‬ ‭Prevent injury‬ ‭-‬ ‭Pt education…‬ ‭-‬ ‭Can cause death + life long complications if progresses‬ ‭-‬ ‭Prevention…‬ ‭-‬ ‭long sleeve clothing outside, insecticide in high risk‬ ‭areas, remain indoors at dawn/dusk, screens on‬ ‭windows, standing water around home removed‬ ‭-‬ ‭ALL cases of arboviruses must be reported to health department‬ ‭-‬ ‭AUTOIMMUNE PROCESSES‬ ‭-‬ ‭MULTIPLE SCLEROSIS‬ ‭-‬ ‭=‬‭immune mediated, progressive, demyelinating disease‬‭of CNS‬ ‭-‬ ‭Impairs nerve impulses‬ ‭-‬ ‭Risk factors…‬ ‭-‬ ‭F > M‬ ‭-‬ ‭Genetic factors but not genetically transmitted‬ ‭-‬ ‭Environmental exposure →‬‭Epstein Barr virus, smoking,‬‭vitamin D‬ ‭deficiency‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Fatigue, depression, weakness, numbness, incoordination, spasticity,‬ ‭pain, paresthesia‬ ‭-‬ ‭Visual disturbances d/t lesions on optic nerve and/or connections‬‭→‬ ‭diplopia, blurry vision‬ ‭-‬ ‭Types…‬ ‭-‬ ‭Relapsing-remitting (RR) - 85%‬ ‭-‬ ‭acute attacks with full recovery‬ ‭-‬ ‭residual effects‬‭with each relapse may‬‭accumulate‬‭over time‬ ‭causing‬‭functional decline‬ ‭-‬ ‭Primary progressive - 15%‬ ‭-‬ s‭ teadily‬‭progress without plateaus and temporary minor‬ ‭improvement‬ ‭-‬ ‭Secondary progressive‬ ‭-‬ ‭begins with‬‭RR followed by variable progression rate‬ ‭-‬ ‭May cause →‬‭quadriparesis, cognitive dysfunction,‬‭visual loss,‬ ‭brainstem syndromes‬ ‭-‬ ‭Progressive relapsing - 5% (least common)‬ ‭-‬ ‭Relapses‬‭with‬‭continuous disabling progressing between‬ ‭exacerbations‬ ‭-‬ ‭t/x…‬ ‭-‬ G ‭ OAL = delay progression of disease, manage chronic s/s, t/x acute‬ ‭exacerbations‬ ‭-‬ ‭No cure for MS‬ ‭-‬ ‭Disease modifying therapy‬‭→ reduce relapse incidence/duration‬‭+ #/size‬ ‭plaques on MRI‬‭in RR‬ ‭-‬ ‭NOT effective in progressive forms‬ ‭-‬ ‭IV methylprednisolone‬‭effective for‬‭RR acute relapses‬‭→‬‭shortens‬ ‭relapse duration‬‭but‬‭no long term benefits‬ ⇒ ‭-‬ ‭Side effects mood swings, weight gain, electrolyte imbalance‬ ‭-‬ ‭Baclofen‬‭→ spasticity‬ ‭-‬ ‭Beta blockers‬‭,‬‭anticonvulsants (gabapentin)‬‭,‬‭benzodiazepines‬ ‭(lorazepam)‬‭→ ataxia‬ ‭-‬ ‭Anticholinergics‬‭/‬‭alpha blockers‬‭/‬‭anti osmotics‬‭agents‬‭→‬ ‭bowel/bladder problems‬ ‭-‬ ‭Vitamin C / ascorbic acid‬‭→ reduce UTI risk‬ ‭-‬ ‭Gerontologic considerations…‬ ‭-‬ ‭5-7 year shorter life expectancy than those without MS‬ ‭-‬ ‭Absorption, distribution, metabolism, excretion of meds may be altered‬ ‭d/t age-related kidney/liver changes‬ ‭-‬ ‭Medication noncompliance r/t high cost‬ ‭-‬ ‭Depression d/t familial burden, marriage concerns, disability, isolation‬ ‭-‬ ‭Increased need for assistance with self-care‬ ‭-‬ ‭MYASTHENIA GRAVIS‬ ‭-‬ ‭=‬‭autoimmune neuromuscular disease causing muscle‬‭weakness‬ ‭-‬ ‭acetylcholine receptor‬‭antibodies‬‭produced‬‭, disrupting‬‭motor function‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Diplopia‬‭,‬‭ptosis (droopy eyelids)‬‭, facial/throat muscle‬‭weakness causes‬ ‭bland facial expression‬‭,‬‭dysphonia‬‭,‬‭dysphagia‬ ‭-‬ ‭Generalized weakness + decreased vital capacity + potential resp failure‬ ‭-‬ ‭MOTOR disorder‬‭, NOT sensory or coordination‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭GOAL = improve function + remove circulating antibodies …‬‭NO cure‬ -‭ ‬ ‭ nticholinesterase + immunosuppressive therapy‬ A ‭-‬ ‭IVIG‬ ‭-‬ ‭TPE (therapeutic plasma exchange)‬‭to t/x exacerbations‬ ‭-‬ ⇒ ‭Surgical management ‬‭thymectomy‬‭to reduce antibody‬‭production‬ ‭-‬ ‭ONLY t/x resulting in‬‭complete remission in 35% pts‬ ‭-‬ ‭Complete thymus gland must be removed‬ ‭-‬ ‭Nursing interventions…‬ ‭-‬ ‭Prevent complications + pt/family education for outpatient…‬ ‭-‬ ‭Energy conservation‬ ‭-‬ ‭Medication compliance →‬‭take at SAME time every day‬ ‭otherwise‬‭can lead to acute resp failure‬ ‭-‬ ‭Prevent ocular complications‬ ‭-‬ ‭GUILLAIN-BARRE SYNDROME‬ ‭-‬ ‭=‬‭autoimmune attack on the peripheral nerve myelin‬ ‭-‬ ‭Rapid segmental demyelination of peripheral nerves‬ ‭-‬ → ‭ ‬ ‭ascending‬‭weakness with dyskinesia‬‭(can’t make‬‭voluntary‬ ‭movements),‬‭hyporeflexia‬‭,‬‭paresthesias‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Muscle weakness + diminished reflexes in LE progressing up‬ ‭-‬ ‭Cranial nerve demyelination‬‭may‬‭cause blindness‬ ‭-‬ ‭peak s/s severity‬‭in‬‭2 weeks‬‭,‬‭lasts 4 weeks‬‭, usually‬‭self-correcting‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭d/t potential of‬‭rapid progression, considered a medical‬‭emergency‬ ‭-‬ ‭RT + mech ventilation may be necessary‬ ‭-‬ ‭Some‬‭may recommend elective intubation before onset‬‭of‬ ‭severe respiratory mm fatigue‬ ‭-‬ ‭Other interventions to prevent mobility complications…‬ ‭-‬ ‭Anticoagulants‬ ‭-‬ ‭SCDs‬‭to prevent VTE/DVT‬ ‭-‬ ‭CRANIAL NERVE DISORDERS‬ ‭-‬ ‭TRIGEMINAL NEURALGIA‬ ‭-‬ ‭Involves‬‭5th‬‭cranial nerve‬ ‭-‬ ‭Sudden‬‭pain to areas‬‭innervated by any‬‭3 branches‬‭of nerve‬ ‭-‬ ‭Pain characterized by‬‭unilateral shooting, stabbing,‬‭burning sensation‬ ‭-‬ ‭Risk factors…‬ ‭-‬ ‭Mostly d/t age (50s-60s)‬ ‭-‬ ‭F > M‬ ‭-‬ ‭pts with MS‬ ‭-‬ ‭Attacks‬‭worsen with progression‬‭→ pt may be in‬‭fear‬‭of having sudden attack‬ ‭-‬ ‭Triggers…‬ ‭-‬ ‭touching/shaving, chewing/drinking, speaking, brushing teeth,‬‭even a‬ ‭breeze‬ ‭-‬ ‭t/x..‬ ‭-‬ t‭ egretol (anticonvulsant)‬‭to‬‭reduce nerve impulse‬‭transmission‬ ‭-‬ ‭gabapentin + baclofen‬‭for‬‭pain contro‬‭l →‬‭phenytoin‬‭as‬‭additive if‬ ‭needed‬ ‭-‬ ‭Surgical options…‬ ‭-‬ ‭microvascular decompression of trigeminal nerve‬ ‭-‬ ‭percutaneous balloon microcompression‬ ‭-‬ ‭radiofrequency thermal coagulation‬ ‭-‬ ‭Nursing interventions…‬ ‭-‬ ‭pain control on outpatient basis‬ ‭-‬ ‭pt education about‬‭prevention‬‭→‬‭room temp water to‬‭wash face‬‭, use‬ ‭mouthwash post-eating if toothbrushing painful‬‭,‬‭personal‬‭hygiene‬ ‭during pain-free intervals‬‭, soft foods /‬‭chew on unaffected‬‭side‬‭,‬ ‭food/fluids at‬‭room temp‬ ‭-‬ ‭BELL PALSY‬ ‭-‬ ‭Involves‬‭7th‬‭cranial nerve‬ ‭-‬ ‭=‬‭unilateral facial paralysis‬ ‭-‬ ‭Possible link to vascular ischemia, autoimmunity, herpes viral infections‬ ‭-‬ ‭Usually in‬‭pts < 45 y/o‬ ‭-‬ ‭s/s..‬ ‭-‬ ‭Painful sensation‬‭to face‬‭behind ear/in eye‬‭,‬‭speech/swallowing‬ ‭difficulties‬‭,‬‭facial paralysis‬‭/distortion,‬‭tearing/lacrimation‬‭occurs‬ ‭-‬ ‭Usually‬‭spontaneous recovery in 3-5 weeks‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭corticosteroids (prednisone)‬‭may‬‭reduce severity‬ ‭(inflammation/edema/reduce vascular compression + restore blood‬ ‭flow)‬ ‭-‬ ‭GOAL =‬‭maintain facial mm tone‬‭,‬‭prevent/minimize denervation‬ ‭-‬ ‭Assure that pt did NOT have stroke and recovery in 3-5 weeks‬ ‭-‬ ‭Analgesics for pain control‬ ‭-‬ ‭Nursing interventions…‬ ‭-‬ ‭Protect eye from injury with paralysis (can’t close eyelids) →‬‭protective‬ ‭eyewear at night + moisturizing eye drops in AM‬ ‭-‬ ‭Massage face‬‭with gently upward motion to‬‭maintain‬‭facial mm tone /‬ ‭prevent atrophy‬ ‭-‬ ‭Prevent breeze/cold exposure‬ ‭CH 65 - ONCOLOGIC or DEGENERATIVE NEURO DISORDER MANAGEMENT‬ ‭ONCOLOGIC‬ ‭-‬ ‭BRAIN TUMORS‬ ‭-‬ ‭Over 100 different types ; 80,000 diagnosed / year (‬‭⅓ malignant‬‭,‬‭⅔ benign‬‭)‬ ‭-‬ ⇒ ‭Primary‬‭ ‬‭originate from cells within brain‬ ‭-‬ ‭s/s…‬ ⇒ ‭-‬ ‭Increased ICP‬‭ headache, vomiting, visual disturbances,‬‭seizures‬ ‭-‬ ‭focal/localized s/s…‬ ⇒ ‭-‬ ‭Parietal‬‭ ‬‭decreased sensation‬‭on‬‭opposite side of‬‭body‬ ⇒ ‭-‬ ‭Temporal‬‭ ‬‭seizures, psych disorders‬ ⇒ ‭-‬ ‭Occipital‬‭ ‬‭visual‬‭manifestations‬ ⇒ ‭-‬ ‭Cerebellar‬‭ ‬‭dizziness, ataxic gait‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Surgery‬ ‭-‬ ‭Remove as much of tumor as possible‬‭w/o increasing‬‭neuro‬ ‭deficit + relieve s/s‬ ‭-‬ ‭Radiation‬‭(if can’t be removed completely)‬ ‭-‬ ‭Decreases incidence of recurrence‬‭of‬‭incompletely‬‭resected‬ ‭tumors‬ ‭-‬ ‭Chemo‬ ‭-‬ ‭Increases survival time‬‭+ can be in‬‭combo with radiation‬ ‭-‬ ‭BBB provides challenge for effective chemo without systemic‬ ‭toxicity‬ ‭-‬ ‭Meds‬ ‭-‬ ‭Corticosteroids‬‭reduce inflammation‬ ‭-‬ ‭Osmotic diuretics‬‭decreased fluid content‬ ‭-‬ ‭Anticonvulsants‬‭for‬‭seizures‬ ‭-‬ ‭Nursing interventions…‬ ‭-‬ ‭Neuro assessment + maintain‬‭documentation‬‭to monitor‬‭trends‬ ‭-‬ ‭including‬‭type of tumor, progression, pt’s wishes‬ ‭-‬ ‭Manage pain → positioning, medication, alternative therapy‬ ‭-‬ ‭Manage N/V‬ ‭-‬ ‭Prevent aspiration‬ ‭-‬ ‭food/fluids to unaffected side, upright positioning during meals,‬ ‭suction equipment available‬ ‭-‬ ‭Pt education‬ ‭-‬ ‭Types…‬ ‭-‬ ‭Gliomas (30%)‬ ‭-‬ ‭Infiltrate surrounding neuro connective tissue‬‭+‬‭difficult‬‭to‬ ‭remove without causing significant damage‬ ‭-‬ ‭M > F‬‭;‬‭50-60 y/o‬ ‭-‬ ‭t/x +‬‭prognosis depends‬‭on type/stage of tumor‬ ‭-‬ ‭Combination of‬‭chemo, radiation, surgery‬ ‭-‬ ‭Meningiomas (15%)‬ ‭-‬ ‭Encapsulated + slow growing‬ ‭-‬ ‭F > M‬‭;‬‭middle-aged‬ -‭ ‬ ‭t/x =‬‭surgical removal + may add radiation‬ ‭-‬ ‭Acoustic neuromas‬ ‭-‬ ‭=‬‭tumor of 8th cranial nerve‬ ‭-‬ ‭Slow growing + benign‬ ⇒ ‭-‬ ‭s/s‬‭when‬‭tumor large‬‭ ‬ ‭hearing loss, tinnitus, vertigo,‬ ‭staggering gait, facial numbness‬ ⇒ ‭-‬ ‭t/x ‬‭surgical removal‬‭with‬‭good prognosis‬ ‭-‬ ‭Can add‬‭stereotactic radiotherapy‬ ‭-‬ ‭Pituitary adenomas‬ ‭-‬ ‭Most slow growing + benign (rarely malignant)‬ ‭-‬ ‭Common among‬‭F of child-bearing age‬ ‭-‬ ‭s/s‬‭d/t‬‭pressure on nearby structures‬‭as they grow‬‭+‬‭vary on‬ ‭based of hormone released‬ ⇒ ‭-‬ ‭ headache, visual disturbances, N/V, sexual‬ ‭dysfunction/infertility, fatigue, nasal drainage, smell‬ ‭changes, sleep/behavioral changes‬ ‭-‬ ‭elevated GH‬‭→‬‭gigantism in children‬‭+‬‭acromegaly in‬‭adults‬ ‭-‬ ‭elevated TSH‬‭→‬‭hyperthyroidism‬ ‭-‬ ‭elevated ACTH‬‭→‬‭Cushing's disease‬ ‭-‬ ‭Gerontologic considerations…‬ ‭-‬ ‭Incidence‬‭of all brain tumors‬‭increases with advancing‬‭age‬ ‭-‬ ‭Early s/s‬‭may be‬‭overlooked/associated‬‭with‬‭normal‬‭aging process‬ ⇒ ‭-‬ ‭ personality change, confusion, gait disturbance, speech‬ ‭dysfunction‬ ‭-‬ ‭Most common‬‭brain tumors…‬ ‭-‬ ‭Anaplastic astrocytoma‬ ‭-‬ ‭Glioblastoma‬ ‭-‬ ‭Cerebral metastases‬ ‭-‬ ⇒ ‭Secondary (metastatic)‬‭ ‬‭originate from lung, GI tract,‬‭pancreas, kidney, skin‬‭and‬ ‭metastasize to brain‬ ‭-‬ ‭2x as common‬‭as‬‭primary tumors‬ ⇒ ‭-‬ ‭Leptomeningeal metastases‬‭ ‬‭metastasis to CSF + meninges‬ ⇒ ‭-‬ ‭s/s ‬‭headache, isolated cranial nerve deficits‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Headache, gait disturbances, visual impairment, personality changes,‬ ‭altered mentation, focal paralysis, aphasia, seizures‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Palliative‬‭→ eliminate/reduce symptoms‬ ‭-‬ ‭steady decline + limited survival without t/x‬ ‭-‬ ‭1st line‬‭→‬‭whole brain radiation therapy‬ ‭-‬ ‭vs… stereotactic radiotherapy (targeted directly at tumor)‬ ‭-‬ ‭single metastasis‬‭→‬‭surgery‬ ‭-‬ ‭Systemic chemo‬‭may be added, either…‬ ‭-‬ ‭directed to primary cause NOT crossing BBB‬ ‭-‬ ‭OR,‬‭crosses BBB / intrathecal (directly into CSF /‬‭spinal tract)‬ ‭-‬ ‭effective for leptomeningeal metastases‬ ‭-‬ ‭Nursing process…‬ ‭-‬ ‭Assess : neuro function, fluid balance, nutritional status (tolerance,‬ ‭preferences), impact on social/home life/self-care‬ ‭-‬ ‭Diagnoses : pain, self care deficit, imbalanced nutrition‬ ‭-‬ ‭Planning : manage pain, compensate for self-care deficits (increase‬ ‭autonomy) + disrupted family processes (pt/family education +‬ ‭encourage familial involvement), improve nutritional status‬ ‭-‬ ‭Evaluation‬ ‭-‬ ‭Verbalized relief of pain, use of assistive devices, eats/accepts‬ ‭alternate nutrition‬ ‭-‬ ‭SPINAL CORD TUMORS‬ ‭-‬ ‭Classified according to anatomical region…‬ ⇒ ‭-‬ ‭Intramedullary‬‭ ‬‭within spinal cord‬‭+‬‭usually primary‬ ⇒ ‭-‬ ‭Extramedullary / intradural‬‭ ‬‭within or under spinal‬‭dura‬ ⇒ ‭-‬ ‭Extramedullary / extradural‬‭ ‬‭outside dural membrane‬ ‭-‬ ‭Pressure causes localized s/s + progressive loss of motor + sensory function…‬ ‭-‬ ‭Pain, weakness, loss of reflexes BELOW level of tumor‬ ‭-‬ ‭Progresses to‬‭paralysis + loss of bowel/bladder function‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Medical:‬ ‭-‬ ‭Primary tumor‬‭=‬‭surgical‬ ‭-‬ ‭Chemo + radiation‬‭may be used as‬‭follow up‬ ⇒ ‭-‬ ‭Pain relief for spinal cord compression‬‭ ‬‭high dose‬‭dexamethasone +‬ ‭radiation‬ ‭-‬ ‭Nursing:‬ ‭-‬ ‭Post-op care‬ ‭-‬ ‭Neuro assessment + pain control‬ ⇒ ‭-‬ ‭Monitor + manage‬‭complications‬‭ ‬‭abnormal breathing,‬‭urinary‬ ‭retention, bleeding, CSF leakage‬ ‭-‬ ‭Assess post-d/c needs‬ ‭DEGENERATIVE DISORDERS‬ ‭-‬ ‭PARKINSON DISEASE‬ ‭-‬ ‭Slow growing progressive neuro movement disorder‬ ‭-‬ ‭decreased dopamine levels‬‭→‬‭altered voluntary movement‬ ‭-‬ ‭M > F‬‭,‬‭s/s usually in 50s y/o‬‭but may be‬‭as early‬‭as 30 y/o‬ ⇒ ‭-‬ ‭s/s tremor, rigidity, bradykinesia, postural instability, sweating, drooling,‬ ‭gastric/urinary retention‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭ O t/x prevents progression‬‭; t/x only for controlling s/s +‬‭improving‬ N ‭independence/QOL‬ ‭-‬ ‭Meds…‬ ‭-‬ ‭Goal = restore dopaminergic / cholinergic activity balance‬ ‭-‬ ‭Levodopa (most effective agent)‬‭→‬‭converts dopamine‬‭in basal‬ ‭ganglia‬‭for s/s relief‬ ‭-‬ ‭Peak effects in first few years of t/x‬‭but‬‭adverse‬‭effects‬ ‭increase severity over time‬ ⇒ ‭-‬ ‭Within‬‭5-10 yrs, develop‬‭dyskinesia‬‭ facial grimacing,‬ ‭rhythmic jerking movement of hands, head bobbing, lip‬ ‭smacking / lip chewing‬ ‭-‬ ‭Therefore,‬‭levodopa delayed as much as‬ ‭possible before initiating‬ ‭-‬ ‭Carbidopa‬‭→ often added to‬‭prevent metabolism of levodopa‬ ‭before reaching brain‬ ‭-‬ ‭Surgical…‬ ‭-‬ ‭Deep brain stimulation‬‭→‬‭surgical implantation of‬‭an electrode‬‭to‬ ‭stimulate dopamine‬ ‭-‬ ‭HUNTINGTON DISEASE‬ ‭-‬ ‭Chronic, progressive, hereditary disorder‬‭→‬‭degeneration‬‭of nerve cells in brain‬ ‭-‬ ‭Inherited through‬‭autosomal DOMINANT gene‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭motor dysfunction (‬‭chorea‬‭),‬‭cognitive impairment‬‭,‬‭mood changes, behavioral‬ ‭feature‬ ‭-‬ ‭gait/speech become impaired/impossible‬ ‭-‬ ‭High suicide risk‬‭in‬‭early disease process‬ ‭-‬ ‭Death usually d/t…‬ ‭-‬ ‭HF, pneumonia, infection, falls, aspiration‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭Goal =‬‭optimize QOL + relieve s/s + prevent progression‬ ‭-‬ ‭NO cure‬ ‭-‬ ‭tetrabenazine‬‭→‬‭chorea‬‭s/s‬ ‭-‬ ‭SSRIs + TCAs‬‭→‬‭depressive‬‭s/s‬ ‭-‬ ‭AMYOTROPHIC LATERAL SCLEROSIS (ALS)‬ ‭-‬ ‭aka‬‭Lou Gehrig disease‬ ‭-‬ ‭unknown cause‬ ‭-‬ ‭causes breakdown of nerve cells‬‭→‬‭reducing muscle‬‭function‬ ‭-‬ ‭Risk factors…‬ ‭-‬ ‭Smoking‬ ‭-‬ ‭40-60 y/o,‬‭M > F‬ ‭-‬ ‭Viral infections‬ ‭-‬ ‭Autoimmune disease‬ -‭ ‬ T‭ oxin exposure‬ ‭-‬ ‭s/s…‬ ‭-‬ ‭Fatigue, progressive muscle weakness, twitching, incoordination, muscle atrophy‬ ‭-‬ ‭25% pts‬‭experience‬‭cranial nerve involvement 1st‬‭→‬‭dysphasia, dysphagia,‬ ‭eventually dyspnea‬ ‭-‬ ‭t/x…‬ ‭-‬ ‭goal = optimize QOL + relieve s/s + prevent progression‬ ‭-‬ ‭NO cure‬ ‭-‬ ‭Discuss EOL issues‬ ‭-‬ ‭Meds…‬ ‭-‬ ‭Riluzole (glutamine agonist)‬‭→‬‭prolong life 3-6 months‬ ‭-‬ ‭Baclofen, dantrolene, diazepam‬→‭ ‬‭improve spasticity‬ ‭-‬ ‭Modafinil‬‭→‬‭improve fatigue‬ ‭-‬ ‭Outcomes..‬ ‭-‬ ‭only‬‭30% pts‬‭have‬‭5 year survival rate‬ ‭-‬ ‭10-20%‬‭live‬‭up to 10 years‬ ‭-‬ ‭5%‬‭survive‬‭> 20 years‬ ‭MUSCULOSKELETAL‬ ‭CH 35 - MUSCULOSKELETAL ASSESSMENT‬ ‭-‬ ‭AP overview‬ ‭-‬ ‭Includes bones, joints, muscles, tendons, ligaments, bursae‬ ⇒ ‭-‬ ‭MS System Functions support body structures + protect vital organs‬ ⇒ ‭-‬ ‭Muscles + tendons allow joints to move‬ ‭-‬ ‭Movement‬‭facilitates return of deoxy blood to R side‬‭heart‬‭+‬‭produce heat‬‭to‬ ‭maintain body temp‬ ‭-‬ ‭> 89% total body Ca stored in bone‬ ‭-‬ ‭diseases/injuries involving MS system → commonly result in disability + death‬ ‭-‬ ‭2.1 million visits / year to ED for falls‬ ‭-‬ ‭Bone Structure + Function…‬ ‭-‬ ‭206 bones … made up of cells, protein matrix, mineral deposits‬ ⇒ ‭-‬ ‭Osteoblasts‬‭ ‬‭secrete bone matrix‬‭(collage + ground‬‭substances)‬ ⇒ ‭-‬ ‭Osteocytes‬‭ ‬‭mature bone cells‬‭involved in‬‭bone maintenance‬ ⇒ ‭-‬ ‭Osteoclasts‬‭ ‬‭multinucleated cells‬‭involved in‬‭dissolving/resorbing‬ ‭bone‬ ‭-‬ ‭4 bone categories…‬ ‭-‬ ‭1)‬‭long‬‭= UE + LE‬ ‭-‬ ‭diaphysis‬‭(shaft) =‬‭cortical bone‬‭(exists where‬‭support‬‭needed‬‭)‬ ‭-‬ ‭ piphyses‬‭(ends) =‬‭cancellous / trabecular bone‬‭(‭h e ‬ ematopoiesis‬ ‭+ bone formation‬‭occurs here)‬ ‭-‬ ‭Epiphyseal plate‬‭separates‬‭diaphysis from diaphysis‬ ‭during childhood‬ ‭-‬ ‭articular cartilage‬‭covers ends =‬‭tough, elastic,‬‭avascular‬ ‭-‬ ‭2)‬‭short‬‭= ankles + hands‬ ‭-‬ ‭3)‬‭flat‬‭=‬‭located‬‭where‬‭protection of underlying structure‬‭needed‬ ‭-‬ ‭4)‬‭irregular‬‭= vertebrae + jaw bones‬ ‭-‬ ‭bone marrow‬‭(vascular)‬‭= in‬‭long shafts of long +‬‭short bones‬ ‭-‬ ‭Bone Formation + Maintenance‬ ‭-‬ ‭Bone = dynamic tissue = constant state of remodeling‬ ‭-‬ ‭Peak bone mass‬‭reached in‬‭early 20s‬ ‭-‬ ‭Bone resorption > bone formation‬‭beginning‬‭35-40 y/o‬ ⇒ ‭-‬ ‭Osteogenesis‬‭ bone formation‬ ‭-‬ ‭Begins before birth‬ ⇒ ‭-‬ ‭Ossification‬‭ ‬‭bone matrix formation‬‭+‬‭crystallization‬‭of Ca/P —> collagen‬ ‭fibers‬ ‭-‬ ‭Ca/P for strength‬‭;‬‭collagen for resistance‬ ‭-‬ ‭Balance of bone remodeling influenced by…‬ ‭-‬ ‭Complete turnover‬‭of skeletal system =‬‭10 years‬ ‭-‬ ‭Physical activity (‬‭weight bearing activities supports‬‭bone maintenance‬‭)‬ ‭-‬ ‭Ex: walking, running‬ ‭-‬ ‭Weight resistance = lifting weights‬ ‭-‬ ‭Diet‬ ‭-‬ ‭Ca: 1000-1200 mg/day‬‭recommended to maintain bone‬‭mass‬ ⇒ ‭-‬ ‭Recommended sources low-fat milk, yogurt, cheese,‬ ‭Ca-fortified OJ/cereal/bread, green leafy veggies‬ ‭-‬ ‭Vitamin D: 600 IU/day = adults ; 800-1000 IU/day = older adults‬ ⇒ ‭-‬ ‭Recommended sources sunlight, fortified-milk (not‬ ‭on it’s own),

Use Quizgecko on...
Browser
Browser